NM_000190.4:c.606G>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000190.4(HMBS):​c.606G>T​(p.Val202Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.266 in 1,546,376 control chromosomes in the GnomAD database, including 56,567 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4502 hom., cov: 32)
Exomes 𝑓: 0.27 ( 52065 hom. )

Consequence

HMBS
NM_000190.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.11

Publications

18 publications found
Variant links:
Genes affected
HMBS (HGNC:4982): (hydroxymethylbilane synthase) This gene encodes a member of the hydroxymethylbilane synthase superfamily. The encoded protein is the third enzyme of the heme biosynthetic pathway and catalyzes the head to tail condensation of four porphobilinogen molecules into the linear hydroxymethylbilane. Mutations in this gene are associated with the autosomal dominant disease acute intermittent porphyria. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
HMBS Gene-Disease associations (from GenCC):
  • acute intermittent porphyria
    Inheritance: SD, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 11-119091520-G-T is Benign according to our data. Variant chr11-119091520-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255485.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.11 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.279 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HMBSNM_000190.4 linkc.606G>T p.Val202Val synonymous_variant Exon 9 of 14 ENST00000652429.1 NP_000181.2 P08397-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HMBSENST00000652429.1 linkc.606G>T p.Val202Val synonymous_variant Exon 9 of 14 NM_000190.4 ENSP00000498786.1 P08397-1

Frequencies

GnomAD3 genomes
AF:
0.235
AC:
35815
AN:
152088
Hom.:
4499
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.166
Gnomad AMI
AF:
0.313
Gnomad AMR
AF:
0.201
Gnomad ASJ
AF:
0.342
Gnomad EAS
AF:
0.171
Gnomad SAS
AF:
0.192
Gnomad FIN
AF:
0.262
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.282
Gnomad OTH
AF:
0.247
GnomAD2 exomes
AF:
0.235
AC:
36676
AN:
155800
AF XY:
0.238
show subpopulations
Gnomad AFR exome
AF:
0.165
Gnomad AMR exome
AF:
0.155
Gnomad ASJ exome
AF:
0.348
Gnomad EAS exome
AF:
0.166
Gnomad FIN exome
AF:
0.260
Gnomad NFE exome
AF:
0.281
Gnomad OTH exome
AF:
0.260
GnomAD4 exome
AF:
0.269
AC:
375557
AN:
1394170
Hom.:
52065
Cov.:
29
AF XY:
0.268
AC XY:
184678
AN XY:
688072
show subpopulations
African (AFR)
AF:
0.163
AC:
5135
AN:
31484
American (AMR)
AF:
0.160
AC:
5720
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.349
AC:
8782
AN:
25142
East Asian (EAS)
AF:
0.159
AC:
5664
AN:
35688
South Asian (SAS)
AF:
0.200
AC:
15807
AN:
79150
European-Finnish (FIN)
AF:
0.251
AC:
12332
AN:
49136
Middle Eastern (MID)
AF:
0.276
AC:
1571
AN:
5686
European-Non Finnish (NFE)
AF:
0.284
AC:
305246
AN:
1074374
Other (OTH)
AF:
0.265
AC:
15300
AN:
57810
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
13553
27106
40659
54212
67765
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10204
20408
30612
40816
51020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.235
AC:
35821
AN:
152206
Hom.:
4502
Cov.:
32
AF XY:
0.234
AC XY:
17419
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.166
AC:
6888
AN:
41548
American (AMR)
AF:
0.201
AC:
3072
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.342
AC:
1187
AN:
3468
East Asian (EAS)
AF:
0.170
AC:
882
AN:
5178
South Asian (SAS)
AF:
0.192
AC:
928
AN:
4822
European-Finnish (FIN)
AF:
0.262
AC:
2778
AN:
10596
Middle Eastern (MID)
AF:
0.235
AC:
69
AN:
294
European-Non Finnish (NFE)
AF:
0.282
AC:
19204
AN:
67988
Other (OTH)
AF:
0.250
AC:
528
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1423
2846
4269
5692
7115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
380
760
1140
1520
1900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.258
Hom.:
10000
Bravo
AF:
0.228
Asia WGS
AF:
0.187
AC:
654
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jul 06, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Acute intermittent porphyria Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital disorder of glycosylation Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
7.1
DANN
Benign
0.81
PhyloP100
2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1131488; hg19: chr11-118962230; COSMIC: COSV53827924; COSMIC: COSV53827924; API